Shibing Deng

10.6k total citations · 1 hit paper
61 papers, 5.7k citations indexed

About

Shibing Deng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shibing Deng has authored 61 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 21 papers in Cancer Research and 19 papers in Oncology. Recurrent topics in Shibing Deng's work include Cancer Genomics and Diagnostics (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Shibing Deng is often cited by papers focused on Cancer Genomics and Diagnostics (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Shibing Deng collaborates with scholars based in United States, China and South Korea. Shibing Deng's co-authors include Hilde Johnsen, Robert Pesich, Charles M. Perou, David Botstein, Anne‐Lise Børresen‐Dale, Robert Tibshirani, Per Eystein Lønning, János Demeter, J. S. Marron and Stephanie Geisler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Shibing Deng

55 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Repeated observation of breast tumor subtypes in independent gene expression data sets

2003 4.0k citations Shibing Deng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shibing Deng United States	23	2.9k	2.7k	2.4k	841	822	61	5.7k
János Demeter United States	27	3.8k 1.3×	2.5k 0.9×	2.4k 1.0×	1.1k 1.3×	613 0.7×	55	6.6k
Joshua F. McMichael United States	11	3.3k 1.2×	2.0k 0.7×	1.5k 0.6×	616 0.7×	789 1.0×	16	5.8k
Ben Ho Park United States	43	5.2k 1.8×	2.2k 0.8×	2.5k 1.0×	1.1k 1.3×	1.5k 1.8×	142	8.0k
Vessela N. Kristensen Norway	37	3.2k 1.1×	2.3k 0.8×	1.4k 0.6×	806 1.0×	644 0.8×	132	5.1k
Jacqui Shaw United Kingdom	39	2.5k 0.9×	2.1k 0.8×	1.6k 0.7×	546 0.6×	754 0.9×	124	5.1k
David Beare United Kingdom	21	4.2k 1.5×	2.2k 0.8×	1.3k 0.5×	963 1.1×	813 1.0×	38	6.1k
Anna DeFazio Australia	35	2.9k 1.0×	1.5k 0.5×	2.9k 1.2×	1.2k 1.4×	667 0.8×	123	6.5k
Johan Vallon‐Christersson Sweden	35	2.9k 1.0×	2.0k 0.7×	1.4k 0.6×	953 1.1×	524 0.6×	90	4.8k
Mark A. Watson United States	48	3.4k 1.2×	1.7k 0.6×	1.9k 0.8×	794 0.9×	1.4k 1.7×	129	7.2k
Dean B. Evans Switzerland	39	2.1k 0.8×	2.0k 0.7×	2.7k 1.1×	2.1k 2.5×	994 1.2×	107	5.6k

Countries citing papers authored by Shibing Deng

Since Specialization

Citations

This map shows the geographic impact of Shibing Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shibing Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shibing Deng more than expected).

Fields of papers citing papers by Shibing Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shibing Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shibing Deng. The network helps show where Shibing Deng may publish in the future.

Co-authorship network of co-authors of Shibing Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Shibing Deng. A scholar is included among the top collaborators of Shibing Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shibing Deng. Shibing Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yaeger, Rona, Jean-François Martini, Lincoln W. Pasquina, et al.. (2025). Clinical Validity of FoundationOne Liquid CDx for Detection of BRAF V600E in Colorectal Cancer. Cancer Research Communications. 5(9). 1566–1573. 1 indexed citations

Rimawi, Mothaffar F., Stephen Johnston, Samuel A. Jacobs, et al.. (2024). Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studies. npj Breast Cancer. 10(1). 54–54.

Bonato, Vinícius, et al.. (2024). Experimental design considerations and statistical analyses in preclinical tumor growth inhibition studies. Pharmaceutical Statistics. 24(1). e2399–e2399.

Pu, Jie, et al.. (2023). Application of statistical machine learning in biomarker selection. Scientific Reports. 13(1). 18331–18331. 3 indexed citations

Rodón, Jordi, Daniel Shao-Weng Tan, Ignacio Garrido‐Laguna, et al.. (2023). Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trial. ESMO Open. 8(4). 101584–101584. 8 indexed citations

Parnell, Andrew, Vimal Chandran, Lara Fallon, et al.. (2022). POS1045 MASS SPECTROMETRY-BASED PROTEOMICS FOR THE IDENTIFICATION OF CANDIDATE SERUM PROTEIN BIOMARKERS THAT MAY PREDICT TREATMENT RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS. Annals of the Rheumatic Diseases. 81. 840–841. 1 indexed citations

Ram, Sripad, Pamela Whalen, Shibing Deng, et al.. (2021). Pixelwise H-score: A novel digital image analysis-based metric to quantify membrane biomarker expression from immunohistochemistry images. PLoS ONE. 16(9). e0245638–e0245638. 33 indexed citations

Gopal, Ajay K., Ronald Levy, Roch Houot, et al.. (2020). First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas. Clinical Cancer Research. 26(11). 2524–2534. 45 indexed citations

Wei, Wei, Jie Ren, Shibing Deng, et al.. (2019). Inhibition of Ctsk modulates periodontitis with arthritis via downregulation of TLR9 and autophagy. Cell Proliferation. 53(1). e12722–e12722. 41 indexed citations

10.

Rytlewski, Julie, Shibing Deng, Tao Xie, et al.. (2019). Model to improve specificity for identification of clinically-relevant expanded T cells in peripheral blood. PLoS ONE. 14(3). e0213684–e0213684. 23 indexed citations

11.

Pan, Weiyi, Xun Xiao, Jinle Li, et al.. (2018). The comparison of biocompatibility and osteoinductivity between multi-walled and single-walled carbon nanotube/PHBV composites. Journal of Materials Science Materials in Medicine. 29(12). 189–189. 13 indexed citations

12.

Pirie‐Shepherd, Steven, Cory L. Painter, Pamela Whalen, et al.. (2017). Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patients. PLoS ONE. 12(7). e0179561–e0179561. 7 indexed citations

13.

Lira, Maruja E., Yoon‐La Choi, Sun Min Lim, et al.. (2014). A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung Cancer. Journal of Molecular Diagnostics. 16(2). 229–243. 88 indexed citations

14.

Neubert, Hendrik, Tracey Clark, Shibing Deng, & Susan Hurst. (2014). Serum β-nerve growth factor concentrations in pregnant female, nonpregnant female, and male cynomolgus monkeys. Neuroreport. 25(11). 829–832. 4 indexed citations

15.

Huang, Donghui, Dong‐Wan Kim, Αthanasios Kotsakis, et al.. (2013). Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment. Genomics. 102(3). 157–162. 34 indexed citations

16.

Lim, Ho-Yeong, Insuk Sohn, Shibing Deng, et al.. (2013). Prediction of Disease-free Survival in Hepatocellular Carcinoma by Gene Expression Profiling. Annals of Surgical Oncology. 20(12). 3747–3753. 110 indexed citations

17.

Fossa, Anthony A., Todd Wisialowski, Thomas I.F.H. Cremers, et al.. (2012). Improved preclinical cardiovascular therapeutic indices with long-term inhibition of norepinephrine reuptake using reboxetine. Toxicology and Applied Pharmacology. 264(3). 343–350. 6 indexed citations

18.

Simic, Damir, et al.. (2008). Drug-Induced Lens Toxicity and Differential Expression of miRNA. Investigative Ophthalmology & Visual Science. 49(13). 2780–2780. 1 indexed citations

19.

Chapin, Robert E., et al.. (2006). Struggles for equivalence: In vitro developmental toxicity model evolution in pharmaceuticals in 2006. Toxicology in Vitro. 21(8). 1545–1551. 19 indexed citations

20.

Chu, Tzu‐Ming, Shibing Deng, Russ Wolfinger, Richard S. Paules, & Hisham K. Hamadeh. (2004). Cross-site comparison of gene expression data reveals high similarity.. Environmental Health Perspectives. 112(4). 449–455. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact